Literature DB >> 7417074

Combined surgery and cryotherapy for diffuse malignant melanoma of the conjunctiva.

F A Jakobiec, S Brownstein, R D Wilkinson, M Khalil, W C Cooper, H R Shibata.   

Abstract

Two patients who had refused exenteration for widespread conjunctival melanoma were treated by a combination of cryotherapy and surgical excisions. Cryotherapy was delivered only to the extensive areas of flat intraepithelial melanocytic proliferation (precancerous melanosis), while the surgical excisions were performed on the focal nodules, representing localized invasive melanoma. In our two patients, the invasive nodules measured, respectively, 1.2 and 1.5 mm in greatest thickness, placing them in a low to borderline risk group for metastasis. Repeated cryoapplicatons were required to control the widespread flat intraepithelial disease. The conjunctiva tolerated these procedures well because the substantia propria is not sacrificed as it must be in surgical conjunctivectomy, allowing comparatively normal reepithelialization to occur from adjacent zones, after the treated epithelium containing the melanocytes sloughs. No evidence of invasive melanoma (cancerous melanosis) has developed in any of the cryotreated areas of intraepithelial disease (precancerous melanosis); sequential biopsies have established that the atypical melanocytes have disappeared from the epithelium.

Entities:  

Mesh:

Year:  1980        PMID: 7417074     DOI: 10.1001/archopht.1980.01020040242005

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Clinical and therapeutical considerations on a case of conjunctival melanoma.

Authors:  M Scrivanti; G P Gini; G R Mastellone; P Malfatti
Journal:  Doc Ophthalmol       Date:  1988-12       Impact factor: 2.379

2.  Management of conjunctival malignant melanoma: a review and update.

Authors:  James R Wong; Afshan A Nanji; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2014-06

Review 3.  Advances in the management of conjunctival melanoma.

Authors:  Gargi K Vora; Hakan Demirci; Brian Marr; Prithvi Mruthyunjaya
Journal:  Surv Ophthalmol       Date:  2016-06-16       Impact factor: 6.048

4.  Conjunctival melanoma after excision of a lentigo maligna melanoma in the ipsilateral eyelid skin.

Authors:  C Hicks; C Liu; M Hiranandani; A Garner; J Hungerford
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

5.  Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.

Authors:  C L Shields
Journal:  Trans Am Ophthalmol Soc       Date:  2000

6.  A prognostic index for patients with malignant melanoma of the conjunctiva.

Authors:  F H Stefani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

7.  Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases.

Authors:  P De Potter; C L Shields; J A Shields; H Menduke
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

Review 8.  Mitomycin: clinical applications in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

9.  Orbital exenteration in 95 cases of primary conjunctival malignant melanoma.

Authors:  A D Paridaens; A C McCartney; D C Minassian; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.